FONDAPARINUX SODIUM

FONDAPARINUX SODIUM was reported 8080 times

FONDAPARINUX SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URETERIC COMPRESSION 12 0.1579
1 SINOBRONCHITIS 17 0.1141
2 INCISION SITE HAEMATOMA 25 0.1078
3 HYPERSENSITIVITY MYOCARDITIS 11 0.0909
4 BRAIN STEM HAEMATOMA 4 0.0870
5 CATHETER THROMBOSIS 8 0.0714
6 POST PROCEDURAL DRAINAGE 8 0.0552
7 MUSCLE HAEMORRHAGE 215 0.0535
8 PERITONEAL HAEMATOMA 8 0.0533
9 CAPNOCYTOPHAGA INFECTION 5 0.0532
10 INTRA-ABDOMINAL HAEMATOMA 64 0.0516
11 SPINAL HAEMATOMA 6 0.0500
12 BREAST HAEMATOMA 10 0.0439
13 INCISION SITE HAEMORRHAGE 34 0.0419
14 THROMBOCYTHAEMIA 20 0.0360
15 GASTRODUODENAL ULCER 15 0.0356
16 POST PROCEDURAL HAEMATOMA 59 0.0350
17 ABDOMINAL WALL HAEMORRHAGE 9 0.0345
18 RETROPERITONEAL HAEMATOMA 74 0.0335
19 BULLOUS HAEMORRHAGIC DERMATOSIS 7 0.0333
20 CONJUNCTIVAL PALLOR 6 0.0331
21 CEREBELLAR HAEMATOMA 9 0.0320
22 ABDOMINAL WALL HAEMATOMA 60 0.0307
23 SPONTANEOUS HAEMATOMA 21 0.0281
24 PERIRENAL HAEMATOMA 6 0.0276
25 PROTHROMBIN LEVEL DECREASED 26 0.0276
26 SPINAL CORD HAEMORRHAGE 11 0.0274
27 OPERATIVE HAEMORRHAGE 12 0.0268
28 ADRENAL HAEMORRHAGE 15 0.0268
29 ANASTOMOTIC HAEMORRHAGE 5 0.0263
30 TRAUMATIC HAEMATOMA 27 0.0251
31 HEPARIN-INDUCED THROMBOCYTOPENIA 123 0.0249
32 HAEMATOMA INFECTION 14 0.0242
33 SUBCUTANEOUS HAEMATOMA 30 0.0235
34 INTRACRANIAL HAEMATOMA 13 0.0231
35 HAEMATOMA 561 0.0216
36 SHOCK HAEMORRHAGIC 174 0.0214
37 PERITONEAL HAEMORRHAGE 29 0.0209
38 HAEMATOMA MUSCLE 24 0.0200
39 ALLERGIC SINUSITIS 17 0.0198
40 BLADDER TAMPONADE 6 0.0198
41 EXTRADURAL HAEMATOMA 26 0.0197
42 COAGULATION FACTOR DECREASED 5 0.0183
43 PELVIC HAEMATOMA 8 0.0181
44 HAEMORRHAGIC ASCITES 5 0.0175
45 URINE COLOUR ABNORMAL 10 0.0175
46 PULPITIS DENTAL 15 0.0159
47 RETROPERITONEAL HAEMORRHAGE 39 0.0158
48 SPLENIC HAEMORRHAGE 8 0.0157
49 CEREBRAL HAEMATOMA 51 0.0152
50 INTRA-ABDOMINAL HAEMORRHAGE 36 0.0151
51 INVESTIGATION 46 0.0147
52 PYELOCALIECTASIS 14 0.0146
53 HAEMORRHAGIC ANAEMIA 63 0.0143
54 CHONDROMALACIA 4 0.0140
55 BRAIN MALFORMATION 5 0.0140
56 CERVICAL CORD COMPRESSION 5 0.0138
57 PUPILS UNEQUAL 15 0.0131
58 TOOTH EROSION 16 0.0131
59 HEPATIC HAEMATOMA 6 0.0127
60 ARTERIAL HAEMORRHAGE 14 0.0122
61 HAEMORRHAGIC DISORDER 13 0.0119
62 BRAIN STEM HAEMORRHAGE 11 0.0116
63 PUNCTURE SITE HAEMORRHAGE 8 0.0113
64 INDURATION 20 0.0112
65 VENOUS THROMBOSIS LIMB 23 0.0111
66 COMPARTMENT SYNDROME 29 0.0111
67 POSTOPERATIVE WOUND COMPLICATION 14 0.0110
68 RENAL VEIN THROMBOSIS 7 0.0104
69 MYOPERICARDITIS 8 0.0103
70 BRAIN HERNIATION 29 0.0097
71 ARTERIAL THROMBOSIS LIMB 4 0.0097
72 ANTEPARTUM HAEMORRHAGE 4 0.0096
73 HAEMORRHAGE SUBCUTANEOUS 34 0.0096
74 CONTRAINDICATION TO MEDICAL TREATMENT 14 0.0092
75 POST PROCEDURAL HAEMORRHAGE 106 0.0091
76 HYPOVOLAEMIC SHOCK 43 0.0090
77 VULVOVAGINAL INJURY 5 0.0088
78 OESOPHAGITIS ULCERATIVE 6 0.0088
79 NEUROLOGICAL DECOMPENSATION 20 0.0086
80 CUSHING'S SYNDROME 6 0.0086
81 MEDIASTINITIS 5 0.0086
82 HYPOPERFUSION 9 0.0086
83 ACCIDENTAL NEEDLE STICK 7 0.0085
84 INTRAVENTRICULAR HAEMORRHAGE 21 0.0084
85 POSTOPERATIVE THROMBOSIS 5 0.0083
86 PERIODONTITIS 17 0.0078
87 VENA CAVA THROMBOSIS 13 0.0078
88 EXTENSOR PLANTAR RESPONSE 7 0.0076
89 BRAIN MIDLINE SHIFT 4 0.0076
90 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 38 0.0075
91 SUBDURAL HAEMATOMA 107 0.0075
92 MELAENA 164 0.0074
93 SKIN NECROSIS 38 0.0073
94 WOUND HAEMORRHAGE 27 0.0073
95 CATHETER RELATED COMPLICATION 8 0.0071
96 THROMBOCYTOSIS 26 0.0071
97 HEPATIC HAEMORRHAGE 6 0.0070
98 CORONARY ARTERY THROMBOSIS 14 0.0069
99 HAEMOTHORAX 20 0.0069
100 HYPOGLYCAEMIA NEONATAL 11 0.0068
101 INCORRECT DRUG ADMINISTRATION DURATION 189 0.0067
102 SUPERINFECTION 10 0.0067
103 SELECTIVE EATING DISORDER 6 0.0066
104 EFFUSION 9 0.0066
105 PERICARDIAL HAEMORRHAGE 14 0.0064
106 VERTEBRAL FORAMINAL STENOSIS 5 0.0061
107 HEMIANOPIA 6 0.0060
108 SMALL INTESTINAL HAEMORRHAGE 12 0.0060
109 SUPERFICIAL VEIN THROMBOSIS 5 0.0059
110 CAROTID ARTERIOSCLEROSIS 6 0.0058
111 COAGULATION TIME PROLONGED 9 0.0058
112 CEREBRAL HAEMORRHAGE 208 0.0058
113 NORMOCHROMIC NORMOCYTIC ANAEMIA 17 0.0057
114 VASCULAR CALCIFICATION 6 0.0056
115 PELVIC VENOUS THROMBOSIS 8 0.0056
116 POST PROCEDURAL SWELLING 6 0.0055
117 PRURIGO 5 0.0054
118 CYTOLYTIC HEPATITIS 18 0.0054
119 HEMIPLEGIA 44 0.0053
120 CAUDA EQUINA SYNDROME 4 0.0052
121 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 4 0.0052
122 MUCOSAL HAEMORRHAGE 6 0.0052
123 HYPOCOAGULABLE STATE 5 0.0051
124 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 9 0.0051
125 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 16 0.0049
126 LEUKOCYTOCLASTIC VASCULITIS 8 0.0049
127 INJECTION SITE HAEMATOMA 71 0.0049
128 PURPURA 43 0.0049
129 VENOUS THROMBOSIS 19 0.0048
130 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 6 0.0048
131 ECCHYMOSIS 33 0.0048
132 AUTOIMMUNE THYROIDITIS 18 0.0048
133 HYPERCOAGULATION 9 0.0047
134 PULMONARY EMBOLISM 449 0.0047
135 HYDROCELE 5 0.0047
136 PHLEBITIS 24 0.0047
137 HAEMATEMESIS 118 0.0047
138 PORTAL VEIN THROMBOSIS 15 0.0046
139 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 5 0.0046
140 THROMBOPHLEBITIS 16 0.0046
141 DEEP VEIN THROMBOSIS 294 0.0045
142 HAEMORRHAGIC STROKE 35 0.0045
143 KLEBSIELLA SEPSIS 5 0.0044
144 SUBDURAL HAEMORRHAGE 12 0.0044
145 WOUND SECRETION 17 0.0043
146 GASTRIC ULCER HAEMORRHAGE 24 0.0043
147 PROTHROMBIN TIME SHORTENED 6 0.0043
148 TOXIC SKIN ERUPTION 43 0.0043
149 SPLENIC RUPTURE 7 0.0043
150 ANAEMIA MACROCYTIC 9 0.0042
151 BLOOD BLISTER 13 0.0042
152 BLEEDING TIME PROLONGED 5 0.0041
153 CATHETER SITE HAEMORRHAGE 10 0.0040
154 JUGULAR VEIN THROMBOSIS 7 0.0039
155 DUODENAL ULCER HAEMORRHAGE 11 0.0038
156 ANURIA 33 0.0038
157 ANAEMIA POSTOPERATIVE 5 0.0038
158 LOBAR PNEUMONIA 7 0.0038
159 DERMATITIS EXFOLIATIVE GENERALISED 13 0.0037
160 PROTEIN TOTAL DECREASED 14 0.0037
161 INTERNATIONAL NORMALISED RATIO DECREASED 15 0.0037
162 HAEMARTHROSIS 33 0.0037
163 THROMBOSIS IN DEVICE 12 0.0037
164 FIBRIN D DIMER INCREASED 13 0.0037
165 HAEMATOCRIT DECREASED 72 0.0036
166 VITREOUS HAEMORRHAGE 10 0.0036
167 AORTIC DILATATION 4 0.0036
168 NECROSIS 20 0.0036
169 DYSAESTHESIA 11 0.0036
170 HAEMODYNAMIC INSTABILITY 27 0.0035
171 CEREBELLAR HAEMORRHAGE 5 0.0035
172 PARAPLEGIA 10 0.0035
173 NASAL POLYPS 17 0.0034
174 PLATELET COUNT INCREASED 45 0.0034
175 HAEMORRHAGE 353 0.0034
176 CARDIAC TAMPONADE 16 0.0034
177 HAEMOGLOBIN DECREASED 339 0.0033
178 THROMBOPHLEBITIS SUPERFICIAL 10 0.0033
179 HEPATITIS ACUTE 21 0.0032
180 INTRACRANIAL PRESSURE INCREASED 18 0.0032
181 MONOPLEGIA 14 0.0032
182 TALIPES 10 0.0032
183 ANAEMIA 610 0.0032
184 IDIOPATHIC THROMBOCYTOPENIC PURPURA 5 0.0032
185 MECHANICAL VENTILATION 6 0.0032
186 GASTROINTESTINAL ULCER 7 0.0032
187 PARESIS 7 0.0031
188 GASTRIC HAEMORRHAGE 36 0.0031
189 COAGULOPATHY 52 0.0031
190 RENAL FAILURE ACUTE 130 0.0031
191 OESOPHAGEAL CANDIDIASIS 12 0.0030
192 CREATININE RENAL CLEARANCE DECREASED 12 0.0030
193 EOSINOPHILIA 52 0.0030
194 WOUND DEHISCENCE 10 0.0030
195 RENAL HAEMORRHAGE 6 0.0029
196 HAEMATURIA 101 0.0029
197 VASCULAR STENT THROMBOSIS 6 0.0029
198 QUADRIPLEGIA 6 0.0029
199 THROMBOSIS 234 0.0029
200 HYPOVOLAEMIA 17 0.0029
201 PALLOR 79 0.0029
202 VIITH NERVE PARALYSIS 10 0.0029
203 HYPOPITUITARISM 5 0.0029
204 RED BLOOD CELL COUNT DECREASED 82 0.0029
205 INFUSION SITE DISCHARGE 5 0.0028
206 CULTURE URINE POSITIVE 4 0.0028
207 VASCULAR OCCLUSION 6 0.0028
208 ESCHERICHIA URINARY TRACT INFECTION 12 0.0028
209 LEUKOCYTOSIS 51 0.0028
210 HAEMORRHAGE INTRACRANIAL 42 0.0028
211 LUNG CANCER METASTATIC 8 0.0028
212 ALTERED STATE OF CONSCIOUSNESS 60 0.0028
213 MONOPARESIS 5 0.0028
214 HYPERTHERMIA 21 0.0027
215 ACUTE ABDOMEN 4 0.0027
216 BACTERIAL TEST POSITIVE 6 0.0027
217 HEPATITIS TOXIC 7 0.0027
218 ADENOCARCINOMA 6 0.0027
219 UPPER GASTROINTESTINAL HAEMORRHAGE 45 0.0027
220 LICHENOID KERATOSIS 6 0.0026
221 WOUND COMPLICATION 9 0.0026
222 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 10 0.0026
223 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 4 0.0026
224 ERYSIPELAS 13 0.0026
225 MULTIPLE MYELOMA 12 0.0026
226 BILIRUBIN CONJUGATED INCREASED 6 0.0026
227 SUBARACHNOID HAEMORRHAGE 26 0.0026
228 DUODENAL ULCER 18 0.0025
229 OCCULT BLOOD POSITIVE 5 0.0025
230 INTESTINAL ISCHAEMIA 14 0.0025
231 PULMONARY INFARCTION 6 0.0025
232 PUSTULE 6 0.0025
233 INTERNATIONAL NORMALISED RATIO INCREASED 72 0.0025
234 RASH MACULO-PAPULAR 56 0.0025
235 PROTHROMBIN TIME PROLONGED 15 0.0025
236 COLON CANCER METASTATIC 4 0.0025
237 HEPATOCELLULAR INJURY 35 0.0025
238 PANCREATIC CARCINOMA METASTATIC 7 0.0025
239 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 19 0.0024
240 LARYNGEAL OEDEMA 15 0.0024
241 ABDOMINAL TENDERNESS 12 0.0024
242 ACUTE CORONARY SYNDROME 20 0.0024
243 GASTROINTESTINAL NECROSIS 7 0.0024
244 LIVEDO RETICULARIS 5 0.0024
245 URINARY BLADDER HAEMORRHAGE 5 0.0024
246 THROMBOCYTOPENIA 264 0.0024
247 MYDRIASIS 30 0.0023
248 BRONCHOPNEUMONIA 8 0.0023
249 CEREBRAL ISCHAEMIA 12 0.0023
250 FACIAL PALSY 5 0.0023
251 MULTI-ORGAN FAILURE 40 0.0023
252 EXPOSED BONE IN JAW 5 0.0023
253 EMBOLISM 19 0.0023
254 CEREBELLAR SYNDROME 5 0.0023
255 DIASTOLIC DYSFUNCTION 7 0.0023
256 BRAIN DEATH 7 0.0023
257 HAEMORRHAGIC DIATHESIS 8 0.0022
258 TEMPERATURE REGULATION DISORDER 5 0.0022
259 ABDOMINAL MASS 6 0.0022
260 GASTROINTESTINAL INJURY 6 0.0022
261 SHOCK 51 0.0022
262 HEPATOCELLULAR DAMAGE 5 0.0022
263 SMALL FOR DATES BABY 11 0.0022
264 DERMATITIS EXFOLIATIVE 11 0.0022
265 CYTOMEGALOVIRUS COLITIS 5 0.0022
266 PULMONARY HAEMORRHAGE 17 0.0022
267 LOCAL SWELLING 37 0.0021
268 SENSORY LOSS 17 0.0021
269 PREMATURE RUPTURE OF MEMBRANES 5 0.0021
270 ARTERIAL THROMBOSIS 4 0.0021
271 SPINAL CORD COMPRESSION 8 0.0021
272 LUMBAR SPINAL STENOSIS 6 0.0021
273 LUNG INFILTRATION 18 0.0020
274 HEMIPARESIS 34 0.0020
275 PARALYSIS 28 0.0020
276 DUODENITIS 6 0.0020
277 HAEMOLYSIS 15 0.0019
278 COMA 92 0.0019
279 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 17 0.0019
280 PETECHIAE 20 0.0019
281 UTERINE HAEMORRHAGE 8 0.0019
282 HYPOTHERMIA 19 0.0019
283 CHOLESTASIS 36 0.0019
284 AREFLEXIA 5 0.0019
285 MOTOR DYSFUNCTION 19 0.0019
286 CIRCULATORY COLLAPSE 31 0.0018
287 GASTROINTESTINAL HAEMORRHAGE 152 0.0018
288 PEPTIC ULCER 6 0.0018
289 RASH MORBILLIFORM 5 0.0018
290 DERMATITIS BULLOUS 13 0.0018
291 HAEMOPTYSIS 50 0.0018
292 RECTAL HAEMORRHAGE 77 0.0018
293 BRAIN NEOPLASM MALIGNANT 8 0.0018
294 ENDOTRACHEAL INTUBATION 5 0.0018
295 IRON DEFICIENCY 8 0.0018
296 BLOOD LOSS ANAEMIA 4 0.0018
297 BRAIN OEDEMA 22 0.0017
298 ISCHAEMIA 8 0.0017
299 FAILURE TO THRIVE 9 0.0017
300 ESCHERICHIA SEPSIS 5 0.0017
301 FLANK PAIN 16 0.0017
302 DISSEMINATED INTRAVASCULAR COAGULATION 24 0.0017
303 GINGIVAL BLEEDING 23 0.0017
304 GASTRIC ULCER 32 0.0017
305 PULSE ABSENT 8 0.0017
306 GAMMA-GLUTAMYLTRANSFERASE INCREASED 37 0.0017
307 DRUG EXPOSURE DURING PREGNANCY 56 0.0016
308 INTRACARDIAC THROMBUS 5 0.0016
309 STAPHYLOCOCCAL SEPSIS 8 0.0016
310 HOSPICE CARE 16 0.0016
311 HEPATIC LESION 7 0.0016
312 JOINT EFFUSION 11 0.0016
313 BLOOD LACTATE DEHYDROGENASE INCREASED 25 0.0016
314 LIVE BIRTH 13 0.0016
315 DIVERTICULUM 11 0.0015
316 BACTERIAL SEPSIS 5 0.0015
317 TRANSAMINASES INCREASED 34 0.0015
318 RESPIRATORY DISTRESS 42 0.0015
319 CARDIAC FAILURE ACUTE 10 0.0015
320 PERFORMANCE STATUS DECREASED 7 0.0015
321 SENSORY DISTURBANCE 24 0.0015
322 HEPATITIS CHOLESTATIC 9 0.0015
323 LOWER GASTROINTESTINAL HAEMORRHAGE 11 0.0015
324 ABDOMINAL RIGIDITY 4 0.0015
325 HYDROCEPHALUS 8 0.0015
326 CLONUS 4 0.0015
327 NON-SMALL CELL LUNG CANCER 7 0.0015
328 HYPERCALCAEMIA 18 0.0015
329 PIGMENTATION DISORDER 9 0.0015
330 GASTROINTESTINAL TOXICITY 7 0.0015
331 OLIGURIA 9 0.0014
332 BLOOD ALKALINE PHOSPHATASE INCREASED 36 0.0014
333 HEPATIC FUNCTION ABNORMAL 54 0.0014
334 DRUG INTERACTION 229 0.0014
335 CAROTID ARTERY STENOSIS 5 0.0014
336 ANAL HAEMORRHAGE 4 0.0014
337 ACUTE PULMONARY OEDEMA 8 0.0014
338 APHASIA 43 0.0014
339 BREATH SOUNDS ABNORMAL 7 0.0014
340 SKIN TOXICITY 8 0.0014
341 LYMPHOPENIA 20 0.0014
342 RETINAL HAEMORRHAGE 10 0.0014
343 OEDEMA PERIPHERAL 171 0.0014
344 ISCHAEMIC STROKE 25 0.0014
345 ERYTHEMA MULTIFORME 13 0.0014
346 BONE LESION 5 0.0014
347 DIVERTICULUM INTESTINAL 6 0.0014
348 MOUTH HAEMORRHAGE 10 0.0014
349 HYPERBILIRUBINAEMIA 14 0.0014
350 CREPITATIONS 4 0.0013
351 LEUKOENCEPHALOPATHY 5 0.0013
352 BLOOD CULTURE POSITIVE 4 0.0013
353 SEPTIC SHOCK 58 0.0013
354 EPISTAXIS 99 0.0013
355 CHEMOTHERAPY 5 0.0013
356 CLOSTRIDIUM DIFFICILE COLITIS 14 0.0013
357 FOETAL GROWTH RESTRICTION 8 0.0013
358 ABDOMINAL HERNIA 6 0.0013
359 IMMUNE THROMBOCYTOPENIA 6 0.0013
360 RENAL FAILURE CHRONIC 10 0.0013
361 HYPOALBUMINAEMIA 10 0.0013
362 DERMATITIS ALLERGIC 16 0.0013
363 ABDOMINAL ADHESIONS 4 0.0013
364 PATENT DUCTUS ARTERIOSUS 5 0.0013
365 GESTATIONAL DIABETES 6 0.0013
366 CHOLECYSTITIS 15 0.0013
367 URINE OUTPUT DECREASED 11 0.0013
368 ELECTROCARDIOGRAM QT PROLONGED 45 0.0012
369 NEPHROPATHY TOXIC 14 0.0012
370 FACE OEDEMA 21 0.0012
371 INTENTIONAL DRUG MISUSE 26 0.0012
372 NEUROLOGICAL SYMPTOM 7 0.0012
373 PERIPHERAL ISCHAEMIA 5 0.0012
374 PLATELET COUNT DECREASED 130 0.0012
375 HYPERAESTHESIA 10 0.0012
376 PLEURAL EFFUSION 74 0.0012
377 INFLAMMATORY MARKER INCREASED 6 0.0012
378 C-REACTIVE PROTEIN INCREASED 44 0.0012
379 BLOOD UREA INCREASED 20 0.0012
380 RESPIRATORY FAILURE 87 0.0012
381 PULMONARY THROMBOSIS 13 0.0012
382 WOUND INFECTION 13 0.0012
383 POSTOPERATIVE WOUND INFECTION 8 0.0012
384 RENAL FAILURE 157 0.0012
385 PATHOLOGICAL FRACTURE 6 0.0012
386 DIARRHOEA HAEMORRHAGIC 11 0.0012
387 FEBRILE BONE MARROW APLASIA 5 0.0012
388 LUNG NEOPLASM 5 0.0012
389 PERIPHERAL VASCULAR DISORDER 6 0.0012
390 RASH GENERALISED 30 0.0012
391 GENERAL PHYSICAL HEALTH DETERIORATION 134 0.0012
392 LYMPHOEDEMA 8 0.0012
393 DERMATITIS ACNEIFORM 7 0.0011
394 HYPERTRANSAMINASAEMIA 8 0.0011
395 APLASTIC ANAEMIA 6 0.0011
396 POST PROCEDURAL COMPLICATION 22 0.0011
397 ATELECTASIS 11 0.0011
398 HYPOXIA 40 0.0011
399 AGRANULOCYTOSIS 21 0.0011
400 OBESITY 18 0.0011
401 TACHYCARDIA 99 0.0011
402 PERITONITIS 23 0.0011
403 MUCOSAL INFLAMMATION 29 0.0011
404 VASCULAR DEVICE INFECTION 5 0.0011
405 BLOOD PRESSURE SYSTOLIC DECREASED 5 0.0011
406 FAECALOMA 6 0.0011
407 WHITE BLOOD CELL COUNT INCREASED 42 0.0011
408 DISEASE COMPLICATION 5 0.0011
409 HYPERKERATOSIS 6 0.0011
410 NERVE COMPRESSION 10 0.0011
411 LUNG DISORDER 53 0.0011
412 PERICARDIAL EFFUSION 25 0.0011
413 INTERVERTEBRAL DISC DEGENERATION 10 0.0011
414 GASTRITIS EROSIVE 5 0.0011
415 PNEUMOTHORAX 17 0.0011
416 SCIATICA 17 0.0011
417 CHRONIC SINUSITIS 4 0.0011
418 HYPOGAMMAGLOBULINAEMIA 7 0.0011
419 PNEUMONITIS 29 0.0011
420 PREMATURE LABOUR 6 0.0011
421 HYPERKALAEMIA 37 0.0011
422 TROPONIN INCREASED 8 0.0011
423 ACUTE MYOCARDIAL INFARCTION 31 0.0011
424 SEPSIS 117 0.0010
425 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
426 LYMPHADENOPATHY 37 0.0010
427 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
428 JOINT RANGE OF MOTION DECREASED 14 0.0010
429 DRUG ADMINISTRATION ERROR 32 0.0010
430 BLOOD BILIRUBIN INCREASED 28 0.0010
431 RALES 6 0.0010
432 GROIN PAIN 9 0.0010
433 SPINAL OSTEOARTHRITIS 9 0.0010
434 SKIN HAEMORRHAGE 15 0.0010
435 PLEURISY 6 0.0010
436 DIABETIC NEUROPATHY 5 0.0010
437 BLOOD ALBUMIN DECREASED 8 0.0010
438 HAEMOLYTIC ANAEMIA 9 0.0010
439 CEREBRAL ATROPHY 4 0.0010
440 CANDIDIASIS 4 0.0010
441 OEDEMA 54 0.0010
442 CYSTITIS HAEMORRHAGIC 4 0.0010
443 INJECTION SITE VESICLES 6 0.0010
444 EMPHYSEMA 10 0.0010
445 KLEBSIELLA INFECTION 5 0.0010
446 EXOSTOSIS 9 0.0010
447 INTESTINAL PERFORATION 11 0.0010
448 ARTHRITIS BACTERIAL 4 0.0010
449 MITRAL VALVE INCOMPETENCE 11 0.0010
450 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 25 0.0010
451 VENTRICULAR TACHYCARDIA 16 0.0010
452 SCOLIOSIS 6 0.0010
453 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
454 STOMACH DISCOMFORT 5 0.0010
455 LUNG INFECTION 15 0.0010
456 DRUG ERUPTION 17 0.0010
457 CONTUSION 92 0.0010
458 TRANSFUSION 10 0.0010
459 BLOOD LACTIC ACID INCREASED 5 0.0009
460 INFUSION SITE ERYTHEMA 8 0.0009
461 BUNDLE BRANCH BLOCK LEFT 4 0.0009
462 AORTIC VALVE INCOMPETENCE 4 0.0009
463 HEPATITIS 24 0.0009
464 COMPRESSION FRACTURE 5 0.0009
465 HYPOKALAEMIA 43 0.0009
466 BODY TEMPERATURE INCREASED 19 0.0009
467 ANOREXIA 12 0.0009
468 BLOOD MAGNESIUM DECREASED 8 0.0009
469 STRESS FRACTURE 5 0.0009
470 PYELONEPHRITIS 8 0.0009
471 PNEUMONIA ASPIRATION 23 0.0009
472 TRANSIENT ISCHAEMIC ATTACK 31 0.0009
473 RENAL TUBULAR NECROSIS 9 0.0009
474 HYPOTENSION 184 0.0009
475 OESOPHAGITIS 10 0.0009
476 PANCYTOPENIA 51 0.0009
477 DEVICE RELATED INFECTION 14 0.0009
478 BLOOD CREATININE INCREASED 59 0.0009
479 VENTRICULAR FIBRILLATION 10 0.0009
480 HYPOCALCAEMIA 17 0.0009
481 PULMONARY ARTERIAL HYPERTENSION 13 0.0009
482 MALNUTRITION 10 0.0009
483 TORSADE DE POINTES 7 0.0009
484 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
485 FISTULA 10 0.0009
486 BLOOD CALCIUM DECREASED 10 0.0009
487 GENERALISED OEDEMA 11 0.0009
488 ABDOMINAL PAIN 206 0.0009
489 ASCITES 26 0.0009
490 TACHYPNOEA 12 0.0009
491 CHOLECYSTITIS ACUTE 5 0.0009
492 FAECES DISCOLOURED 19 0.0009
493 MIOSIS 7 0.0009
494 INFLAMMATION 45 0.0009
495 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
496 ABDOMINAL PAIN LOWER 22 0.0009
497 ASPARTATE AMINOTRANSFERASE INCREASED 46 0.0009
498 LEUKOPENIA 43 0.0009
499 CEREBRAL INFARCTION 21 0.0009
500 DYSARTHRIA 32 0.0008
501 HIATUS HERNIA 11 0.0008
502 OSTEONECROSIS OF JAW 21 0.0008
503 PRODUCT QUALITY ISSUE 114 0.0008
504 BREAST CANCER METASTATIC 9 0.0008
505 ANGINA PECTORIS 24 0.0008
506 CARDIOGENIC SHOCK 12 0.0008
507 GANGRENE 5 0.0008
508 ADRENAL INSUFFICIENCY 10 0.0008
509 RASH PUSTULAR 6 0.0008
510 CARDIO-RESPIRATORY ARREST 34 0.0008
511 DISORIENTATION 32 0.0008
512 HYPOTONIA 8 0.0008
513 ALANINE AMINOTRANSFERASE INCREASED 49 0.0008
514 PANCREATIC CARCINOMA 23 0.0008
515 HEPATIC FAILURE 24 0.0008
516 NEOPLASM MALIGNANT 53 0.0008
517 ACUTE RESPIRATORY DISTRESS SYNDROME 14 0.0008
518 CARDIAC ARREST 65 0.0008
519 DRUG LEVEL INCREASED 13 0.0008
520 SKIN DISCOLOURATION 36 0.0008
521 BLOOD PRESSURE DECREASED 52 0.0008
522 PROCEDURAL COMPLICATION 6 0.0008
523 SKIN REACTION 11 0.0008
524 BLINDNESS UNILATERAL 11 0.0008
525 ACUTE RESPIRATORY FAILURE 15 0.0008
526 INFUSION SITE PAIN 10 0.0008
527 MUSCULOSKELETAL CHEST PAIN 12 0.0008
528 POOR VENOUS ACCESS 8 0.0008
529 DRUG SPECIFIC ANTIBODY PRESENT 5 0.0008
530 PULMONARY HYPERTENSION 16 0.0008
531 DEHYDRATION 102 0.0008
532 POLYP 5 0.0008
533 METRORRHAGIA 13 0.0008
534 DEPRESSED LEVEL OF CONSCIOUSNESS 30 0.0008
535 GRAND MAL CONVULSION 7 0.0008
536 PANCREATITIS ACUTE 17 0.0008
537 RENAL CYST 6 0.0008
538 LUNG NEOPLASM MALIGNANT 31 0.0008
539 CHROMATURIA 17 0.0008
540 MULTIPLE ORGAN DYSFUNCTION SYNDROME 21 0.0007
541 BEHAVIOUR DISORDER 4 0.0007
542 NEUTROPENIA 100 0.0007
543 CARDIOMEGALY 9 0.0007
544 PHARMACEUTICAL PRODUCT COMPLAINT 19 0.0007
545 METASTASES TO BONE 12 0.0007
546 INFARCTION 5 0.0007
547 ESCHERICHIA INFECTION 6 0.0007
548 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 17 0.0007
549 HYPONATRAEMIA 41 0.0007
550 ILEUS 9 0.0007
551 EXPOSURE DURING PREGNANCY 45 0.0007
552 LARGE INTESTINE PERFORATION 5 0.0007
553 DYSPNOEA EXERTIONAL 27 0.0007
554 RIGHT VENTRICULAR FAILURE 5 0.0007
555 MENORRHAGIA 14 0.0007
556 SKIN PLAQUE 6 0.0007
557 JAUNDICE 19 0.0007
558 CONFUSIONAL STATE 114 0.0007
559 MYOCARDIAL ISCHAEMIA 8 0.0007
560 BRONCHOSPASM 10 0.0007
561 INTERNAL HAEMORRHAGE 8 0.0007
562 PRESYNCOPE 17 0.0007
563 METASTASES TO CENTRAL NERVOUS SYSTEM 9 0.0007
564 PYREXIA 240 0.0007
565 ABSCESS 11 0.0007
566 DRUG LEVEL DECREASED 7 0.0007
567 NAIL DISORDER 6 0.0007
568 GASTRITIS 18 0.0007
569 NEUTROPHIL COUNT INCREASED 7 0.0007
570 BRADYCARDIA 36 0.0007
571 NERVOUS SYSTEM DISORDER 21 0.0007
572 CARDIOTOXICITY 6 0.0007
573 HYDRONEPHROSIS 5 0.0007
574 INTESTINAL OBSTRUCTION 25 0.0007
575 INCONTINENCE 7 0.0007
576 SUDDEN DEATH 7 0.0007
577 INTERSTITIAL LUNG DISEASE 32 0.0007
578 URINARY RETENTION 22 0.0007
579 HYPERGLYCAEMIA 24 0.0007
580 PAIN IN EXTREMITY 194 0.0007
581 SKIN LESION 18 0.0007
582 BRAIN NEOPLASM 6 0.0007
583 HYPOMAGNESAEMIA 9 0.0006
584 OXYGEN SATURATION DECREASED 36 0.0006
585 CHOLELITHIASIS 21 0.0006
586 ASPIRATION 7 0.0006
587 STAPHYLOCOCCAL INFECTION 21 0.0006
588 CYANOSIS 10 0.0006
589 SINUS TACHYCARDIA 9 0.0006
590 OSTEOPOROSIS 26 0.0006
591 TRICUSPID VALVE INCOMPETENCE 5 0.0006
592 ULCER 10 0.0006
593 INJECTION SITE IRRITATION 8 0.0006
594 SYRINGE ISSUE 11 0.0006
595 GINGIVAL PAIN 5 0.0006
596 HEPATIC CYTOLYSIS 8 0.0006
597 ATRIAL FIBRILLATION 61 0.0006
598 BLOOD DISORDER 5 0.0006
599 RHABDOMYOLYSIS 26 0.0006
600 PRESCRIBED OVERDOSE 12 0.0006
601 STATUS EPILEPTICUS 7 0.0006
602 DECUBITUS ULCER 5 0.0006
603 BRADYPHRENIA 4 0.0006
604 MYOCARDITIS 7 0.0006
605 BODY TEMPERATURE DECREASED 6 0.0006
606 IMPAIRED HEALING 20 0.0006
607 METASTASES TO LUNG 7 0.0006
608 CHEST PAIN 111 0.0006
609 ATRIOVENTRICULAR BLOCK COMPLETE 4 0.0006
610 ATRIAL SEPTAL DEFECT 5 0.0006
611 CONVULSION 34 0.0006
612 DYSPHAGIA 56 0.0006
613 BACTERAEMIA 7 0.0006
614 MALIGNANT NEOPLASM PROGRESSION 60 0.0006
615 CARDIAC FAILURE 47 0.0006
616 OVERDOSE 125 0.0006
617 HEPATIC ENZYME INCREASED 39 0.0006
618 RASH MACULAR 20 0.0006
619 SCRATCH 6 0.0006
620 RESPIRATORY DISORDER 17 0.0006
621 IMMUNOSUPPRESSION 5 0.0006
622 SWELLING 53 0.0006
623 ANGIOEDEMA 25 0.0006
624 PAIN IN JAW 16 0.0006
625 ERYTHEMA 116 0.0006
626 PLASMA CELL MYELOMA 22 0.0006
627 LOSS OF CONSCIOUSNESS 72 0.0006
628 HAEMATOCHEZIA 31 0.0006
629 RENAL IMPAIRMENT 47 0.0006
630 ECZEMA 29 0.0006
631 SKIN LACERATION 6 0.0006
632 CEREBROVASCULAR ACCIDENT 93 0.0005
633 RASH ERYTHEMATOUS 26 0.0005
634 INCREASED TENDENCY TO BRUISE 5 0.0005
635 DENTAL CARIES 6 0.0005
636 INJECTION SITE INDURATION 7 0.0005
637 HYPERTENSIVE CRISIS 6 0.0005
638 PREMATURE BABY 16 0.0005
639 LIVER INJURY 13 0.0005
640 ENCEPHALOPATHY 13 0.0005
641 HIP FRACTURE 17 0.0005
642 SOPOR 7 0.0005
643 EYE HAEMORRHAGE 7 0.0005
644 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
645 ACCIDENTAL OVERDOSE 19 0.0005
646 LIVER DISORDER 23 0.0005
647 LIVER FUNCTION TEST ABNORMAL 15 0.0005
648 MUSCULOSKELETAL PAIN 27 0.0005
649 NEEDLE ISSUE 15 0.0005
650 AUTOIMMUNE DISORDER 5 0.0005
651 HAEMORRHOIDS 10 0.0005
652 CORONARY ARTERY OCCLUSION 7 0.0005
653 SYNCOPE 51 0.0005
654 SKIN DISORDER 17 0.0005
655 ARTERIAL OCCLUSIVE DISEASE 4 0.0005
656 RESPIRATORY ARREST 14 0.0005
657 BLOOD IRON DECREASED 6 0.0005
658 BLADDER DISORDER 5 0.0005
659 HYPERLIPIDAEMIA 6 0.0005
660 ATRIAL FLUTTER 4 0.0005
661 BLISTER 28 0.0005
662 DEVICE OCCLUSION 7 0.0005
663 SPEECH DISORDER 26 0.0005
664 VOMITING 233 0.0005
665 BONE DISORDER 9 0.0005
666 BLOOD POTASSIUM INCREASED 8 0.0005
667 BONE MARROW FAILURE 10 0.0005
668 FALL 163 0.0005
669 HEART RATE IRREGULAR 11 0.0005
670 MEDICATION ERROR 27 0.0005
671 HYPERTHYROIDISM 7 0.0005
672 DISTURBANCE IN ATTENTION 26 0.0005
673 DYSPNOEA 272 0.0005
674 CELLULITIS 24 0.0005
675 BLOOD URINE PRESENT 9 0.0005
676 CARDIOMYOPATHY 7 0.0005
677 HALLUCINATION, VISUAL 10 0.0005
678 ASTHENIA 178 0.0005
679 CARDIOVASCULAR DISORDER 12 0.0005
680 INJURY 33 0.0005
681 PULMONARY OEDEMA 21 0.0005
682 DRUG PRESCRIBING ERROR 9 0.0005
683 MUSCULAR WEAKNESS 53 0.0005
684 TOXIC EPIDERMAL NECROLYSIS 7 0.0005
685 ORTHOSTATIC HYPOTENSION 8 0.0005
686 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
687 ORAL CANDIDIASIS 6 0.0005
688 HEART RATE DECREASED 16 0.0005
689 METASTASES TO LIVER 8 0.0005
690 PULMONARY CONGESTION 6 0.0005
691 HYPERTENSION 96 0.0005
692 TENDONITIS 7 0.0005
693 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
694 URTICARIA 75 0.0004
695 PRODUCT PHYSICAL ISSUE 9 0.0004
696 VERTIGO 27 0.0004
697 EYE INFECTION 5 0.0004
698 URINARY INCONTINENCE 13 0.0004
699 INJECTION SITE HAEMORRHAGE 35 0.0004
700 METABOLIC ACIDOSIS 14 0.0004
701 PERIPHERAL COLDNESS 6 0.0004
702 ORAL DISCOMFORT 6 0.0004
703 CONJUNCTIVITIS 8 0.0004
704 EYELID OEDEMA 5 0.0004
705 HEPATIC STEATOSIS 8 0.0004
706 VASCULITIS 5 0.0004
707 ANAPHYLACTIC SHOCK 11 0.0004
708 SKIN ULCER 11 0.0004
709 OFF LABEL USE 372 0.0004
710 COVID-19 PNEUMONIA 5 0.0004
711 AGITATION 31 0.0004
712 FOOT FRACTURE 8 0.0004
713 POLYNEUROPATHY 5 0.0004
714 VAGINAL HAEMORRHAGE 18 0.0004
715 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
716 HEAD INJURY 13 0.0004
717 INJECTION SITE URTICARIA 10 0.0004
718 DYSURIA 15 0.0004
719 LABORATORY TEST ABNORMAL 12 0.0004
720 TENDON RUPTURE 5 0.0004
721 HEPATOTOXICITY 9 0.0004
722 PULMONARY MASS 6 0.0004
723 COLON CANCER 6 0.0004
724 IMMUNODEFICIENCY 6 0.0004
725 SECRETION DISCHARGE 5 0.0004
726 COLD SWEAT 7 0.0004
727 MENTAL STATUS CHANGES 11 0.0004
728 OSTEOPENIA 6 0.0004
729 MUSCLE ATROPHY 5 0.0004
730 FOETAL EXPOSURE DURING PREGNANCY 32 0.0004
731 INJURY ASSOCIATED WITH DEVICE 8 0.0004
732 ACUTE KIDNEY INJURY 60 0.0004
733 HYPOGLYCAEMIA 19 0.0004
734 FEMUR FRACTURE 12 0.0004
735 MYOCARDIAL INFARCTION 67 0.0004
736 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20 0.0004
737 DERMATITIS 8 0.0004
738 MATERNAL EXPOSURE DURING PREGNANCY 34 0.0004
739 BEDRIDDEN 5 0.0004
740 ANAPHYLACTIC REACTION 21 0.0004
741 FEBRILE NEUTROPENIA 25 0.0004
742 EATING DISORDER 8 0.0004
743 SURGERY 22 0.0004
744 DELIRIUM 13 0.0004
745 MALIGNANT MELANOMA 5 0.0004
746 DISEASE PROGRESSION 44 0.0004
747 BLOOD SODIUM DECREASED 7 0.0004
748 NEURALGIA 9 0.0004
749 URINARY TRACT INFECTION 63 0.0004
750 COLITIS 14 0.0004
751 DYSPEPSIA 36 0.0004
752 COGNITIVE DISORDER 17 0.0004
753 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
754 MOBILITY DECREASED 26 0.0004
755 CYTOMEGALOVIRUS INFECTION 6 0.0004
756 PNEUMONIA 113 0.0003
757 CYTOKINE RELEASE SYNDROME 7 0.0003
758 ILL-DEFINED DISORDER 21 0.0003
759 ABDOMINAL DISTENSION 36 0.0003
760 DEATH 297 0.0003
761 BACK PAIN 80 0.0003
762 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
763 CAESAREAN SECTION 4 0.0003
764 MOVEMENT DISORDER 11 0.0003
765 BONE PAIN 20 0.0003
766 NIGHT SWEATS 11 0.0003
767 MALAISE 149 0.0003
768 INJECTION SITE SWELLING 26 0.0003
769 DIARRHOEA 217 0.0003
770 INCORRECT ROUTE OF DRUG ADMINISTRATION 12 0.0003
771 HYPERSENSITIVITY 62 0.0003
772 CHILLS 39 0.0003
773 PARAESTHESIA 52 0.0003
774 BLOOD COUNT ABNORMAL 5 0.0003
775 DRUG DISPENSING ERROR 5 0.0003
776 PRURITUS 125 0.0003
777 PHARYNGEAL OEDEMA 5 0.0003
778 DIVERTICULITIS 9 0.0003
779 ABASIA 8 0.0003
780 PRURITUS GENERALISED 7 0.0003
781 LYMPHOMA 5 0.0003
782 FEELING COLD 9 0.0003
783 WEIGHT DECREASED 90 0.0003
784 NECK PAIN 18 0.0003
785 WOUND 9 0.0003
786 EJECTION FRACTION DECREASED 5 0.0003
787 BACTERIAL INFECTION 6 0.0003
788 HYPOAESTHESIA 48 0.0003
789 BASAL CELL CARCINOMA 5 0.0003
790 DRUG-INDUCED LIVER INJURY 10 0.0003
791 ARRHYTHMIA 15 0.0003
792 PROTEINURIA 6 0.0003
793 FLUID RETENTION 16 0.0003
794 SLEEP APNOEA SYNDROME 6 0.0003
795 HYPOTHYROIDISM 10 0.0003
796 PULMONARY FIBROSIS 6 0.0003
797 RASH PAPULAR 7 0.0003
798 POLLAKIURIA 13 0.0003
799 UNRESPONSIVE TO STIMULI 8 0.0003
800 RESPIRATORY TRACT INFECTION 8 0.0003
801 OSTEOARTHRITIS 13 0.0003
802 SEDATION 8 0.0003
803 SINUS DISORDER 6 0.0003
804 CHRONIC KIDNEY DISEASE 23 0.0003
805 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
806 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
807 ASTHMA 34 0.0003
808 DRUG INTOLERANCE 29 0.0003
809 SOMNOLENCE 60 0.0003
810 CORONARY ARTERY DISEASE 9 0.0003
811 HERPES ZOSTER 17 0.0003
812 NAUSEA 234 0.0003
813 NEUTROPHIL COUNT DECREASED 12 0.0003
814 CONDITION AGGRAVATED 88 0.0003
815 PROCEDURAL PAIN 8 0.0003
816 NEOPLASM PROGRESSION 10 0.0003
817 WHITE BLOOD CELL COUNT DECREASED 31 0.0003
818 FLUSHING 29 0.0003
819 MOUTH ULCERATION 6 0.0003
820 BLOOD TEST ABNORMAL 4 0.0003
821 LYMPHOCYTE COUNT DECREASED 5 0.0003
822 JOINT SWELLING 34 0.0003
823 IMPAIRED WORK ABILITY 6 0.0003
824 HOSPITALISATION 43 0.0003
825 CARDIAC DISORDER 26 0.0003
826 GASTROENTERITIS VIRAL 5 0.0003
827 TOOTHACHE 5 0.0003
828 PELVIC PAIN 5 0.0003
829 UNDERDOSE 20 0.0003
830 ABDOMINAL PAIN UPPER 56 0.0003
831 PAIN 167 0.0003
832 DYSGEUSIA 20 0.0003
833 ORAL PAIN 6 0.0003
834 INJECTION SITE PAIN 82 0.0003
835 DECREASED APPETITE 62 0.0003
836 BLOOD POTASSIUM DECREASED 8 0.0003
837 STOMATITIS 16 0.0003
838 ROAD TRAFFIC ACCIDENT 11 0.0003
839 NEUROPATHY PERIPHERAL 25 0.0003
840 NEPHROLITHIASIS 12 0.0003
841 AGGRESSION 13 0.0003
842 LIMB DISCOMFORT 8 0.0003
843 LIMB INJURY 7 0.0003
844 ACUTE MYELOID LEUKAEMIA 4 0.0003
845 DYSPHONIA 15 0.0003
846 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
847 INFECTION 37 0.0003
848 HEADACHE 160 0.0003
849 KIDNEY INFECTION 5 0.0003
850 COUGH 71 0.0003
851 INJECTION SITE BRUISING 20 0.0003
852 BLOOD PRESSURE FLUCTUATION 6 0.0002
853 MYELOSUPPRESSION 9 0.0002
854 FULL BLOOD COUNT DECREASED 5 0.0002
855 LOCALISED INFECTION 6 0.0002
856 AMNESIA 16 0.0002
857 ARTHRALGIA 102 0.0002
858 BALANCE DISORDER 21 0.0002
859 ADVERSE EVENT 22 0.0002
860 SKIN EXFOLIATION 20 0.0002
861 GAIT DISTURBANCE 45 0.0002
862 INFLUENZA 26 0.0002
863 INCORRECT DOSE ADMINISTERED 53 0.0002
864 DIPLOPIA 6 0.0002
865 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
866 RASH 100 0.0002
867 ANHEDONIA 6 0.0002
868 INJECTION SITE RASH 7 0.0002
869 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
870 CYSTITIS 7 0.0002
871 RESTLESSNESS 8 0.0002
872 CARDIAC FAILURE CONGESTIVE 17 0.0002
873 ANXIETY 60 0.0002
874 VISUAL ACUITY REDUCED 7 0.0002
875 GAIT INABILITY 7 0.0002
876 LETHARGY 12 0.0002
877 DIZZINESS 104 0.0002
878 DEPRESSED MOOD 11 0.0002
879 MENTAL IMPAIRMENT 5 0.0002
880 BRONCHITIS 15 0.0002
881 EXTRAPYRAMIDAL DISORDER 5 0.0002
882 PERIPHERAL SWELLING 31 0.0002
883 TREATMENT NONCOMPLIANCE 11 0.0002
884 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0002
885 GASTRIC CANCER 5 0.0002
886 DRUG INEFFECTIVE 259 0.0002
887 FEELING HOT 12 0.0002
888 HYPOPHAGIA 5 0.0002
889 OROPHARYNGEAL PAIN 18 0.0002
890 INFLUENZA LIKE ILLNESS 16 0.0002
891 JOINT STIFFNESS 5 0.0002
892 INJECTION SITE REACTION 13 0.0002
893 CONSTIPATION 41 0.0002
894 PALPITATIONS 22 0.0002
895 FREQUENT BOWEL MOVEMENTS 5 0.0002
896 RASH PRURITIC 10 0.0002
897 FATIGUE 142 0.0002
898 MYALGIA 31 0.0002
899 VISION BLURRED 25 0.0002
900 ABNORMAL DREAMS 5 0.0002
901 LIP SWELLING 6 0.0002
902 MUSCLE SPASMS 33 0.0002
903 HYPERHIDROSIS 23 0.0002
904 TINNITUS 8 0.0002
905 ALOPECIA 34 0.0002
906 DRY MOUTH 14 0.0002
907 HALLUCINATION 13 0.0002
908 DYSKINESIA 7 0.0002
909 RENAL DISORDER 8 0.0002
910 HEART RATE INCREASED 17 0.0002
911 PRODUCT USE ISSUE 32 0.0002
912 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 12 0.0002
913 WITHDRAWAL SYNDROME 7 0.0002
914 LACRIMATION INCREASED 5 0.0002
915 EMOTIONAL DISTRESS 20 0.0002
916 BLOOD PRESSURE INCREASED 25 0.0002
917 AGEUSIA 4 0.0002
918 MEMORY IMPAIRMENT 22 0.0002
919 SWOLLEN TONGUE 5 0.0002
920 MUSCULOSKELETAL STIFFNESS 14 0.0002
921 FLATULENCE 9 0.0002
922 BURNING SENSATION 11 0.0002
923 CHEST DISCOMFORT 16 0.0002
924 LACTIC ACIDOSIS 5 0.0002
925 DEAFNESS 4 0.0002
926 ARTHRITIS 12 0.0002
927 OSTEONECROSIS 5 0.0002
928 WHEEZING 9 0.0002
929 ABNORMAL BEHAVIOUR 6 0.0002
930 CATARACT 9 0.0002
931 FUNGAL INFECTION 5 0.0001
932 TYPE 2 DIABETES MELLITUS 5 0.0001
933 THERAPEUTIC RESPONSE DECREASED 9 0.0001
934 PRODUCTIVE COUGH 7 0.0001
935 UNEVALUABLE EVENT 11 0.0001
936 DEVICE LEAKAGE 6 0.0001
937 THERAPY CESSATION 7 0.0001
938 MIGRAINE 13 0.0001
939 INFUSION RELATED REACTION 9 0.0001
940 INJECTION SITE MASS 5 0.0001
941 INJECTION SITE PRURITUS 9 0.0001
942 GASTROINTESTINAL DISORDER 12 0.0001
943 ADVERSE DRUG REACTION 12 0.0001
944 FEELING ABNORMAL 32 0.0001
945 DERMATITIS ATOPIC 7 0.0001
946 TREMOR 22 0.0001
947 PANCREATITIS 7 0.0001
948 INSOMNIA 35 0.0001
949 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
950 VISUAL IMPAIRMENT 16 0.0001
951 INJECTION SITE ERYTHEMA 16 0.0001
952 BLOOD CHOLESTEROL INCREASED 6 0.0001
953 BONE DENSITY DECREASED 4 0.0001
954 MULTIPLE SCLEROSIS 6 0.0001
955 WEIGHT INCREASED 28 0.0001
956 BLOOD GLUCOSE DECREASED 6 0.0001
957 ABORTION SPONTANEOUS 5 0.0001
958 NASOPHARYNGITIS 23 0.0001
959 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
960 DRUG DOSE OMISSION 19 0.0001
961 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
962 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
963 SKIN IRRITATION 5 0.0001
964 TREATMENT FAILURE 9 0.0001
965 RHINORRHOEA 7 0.0001
966 EYE PAIN 6 0.0001
967 DISEASE RECURRENCE 5 0.0001
968 DRY EYE 5 0.0001
969 IRRITABILITY 6 0.0001
970 SLEEP DISORDER 7 0.0001
971 HOT FLUSH 7 0.0001
972 DRUG EFFECT DECREASED 5 0.0001
973 SWELLING FACE 6 0.0001
974 DIABETES MELLITUS 7 0.0001
975 COVID-19 16 0.0001
976 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
977 ARTHROPATHY 5 0.0001
978 DRY SKIN 12 0.0001
979 PRODUCT USE IN UNAPPROVED INDICATION 22 0.0001
980 SINUSITIS 9 0.0001
981 ILLNESS 9 0.0001
982 PRODUCT SUBSTITUTION ISSUE 5 0.0001
983 DEPRESSION 19 0.0001
984 ABDOMINAL DISCOMFORT 14 0.0001
985 SEIZURE 9 0.0001
986 BLOOD GLUCOSE INCREASED 14 0.0001
987 SKIN BURNING SENSATION 5 0.0001
988 RHEUMATOID ARTHRITIS 7 0.0001
989 DEVICE ISSUE 5 0.0001
990 BREAST CANCER 5 0.0001
991 ACNE 4 0.0001
992 NO ADVERSE EVENT 8 0.0000
993 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
994 TOXICITY TO VARIOUS AGENTS 6 0.0000
995 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
996 PRODUCT DOSE OMISSION ISSUE 8 0.0000